| Duloxetine (50) | Placebo (50) | P |
---|---|---|---|
Age | 67.8 ± 10.12 | 66.2 ± 9.83 | 0.430 |
Female | 30 (60%) | 27 (54%) | 0.622 |
Height | 1.58 ± 0.08 | 1.60 ± 0.09 | 0.243 |
Weight | 62.97 ± 10.21 | 63.13 ± 9.92 | 0.937 |
BMI | 24.67 ± 4.35 | 24.83 ± 3.87 | 0.846 |
rVAS | 3.47 ± 1.77 | 3.62 ± 2.02 | 0.694 |
aVAS | 6.31 ± 2.35 | 6.52 ± 2.60 | 0.673 |
aROM | 100.37 ± 14.21 | 102.72 ± 13.52 | 0.399 |
pROM | 104.12 ± 14.69 | 107.29 ± 14.37 | 0.278 |
ASA ІІ/ІІІ | 43/7 | 47/3 | 0.182 |
HAMD | 3.2 ± 1.1 | 3.1 ± 1.1 | 0.650 |
HAMA | 3.1 ± 1.3 | 3.3 ± 1.2 | 0.426 |
Kellgren-Lawrence (K-L) grade III/IV | 37/13 | 36/14 | 0.822 |
Preoperative medications | |||
 NSAIDs | 12 (24) | 15 (30) | 0.499 |
 Acetaminophen | 2 (4) | 2 (4) | 1.000 |
 Opioids | 0 | 0 | 1.000 |
 Antidepressant | 0 | 0 | 1.000 |